PTX3 and neoplasm: Interestingly, doxorubicin treatment enhances doxorubicin-induced tumor metastasis in mouse xenograft models by priming the premetastatic niche in a PTX3-dependent manner, and promotes the secretion of TNBC-EVs enriched in PTX3 [149].